CELYSTRA’s Dawnzera Approved in Canada for Hereditary Angioedema CELYSTRA Pharma announced that Health Canada has approved Dawnzera (donidalorsen) to prevent hereditary angioedema (HAE) attacks in adu...
CELYSTRA’s Dawnzera Approved in Canada for Hereditary Angioedema CELYSTRA Pharma announced that Health Canada has approved Dawnzera (donidalorsen) to prevent hereditary angioedema (HAE) attacks in adu...